MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.180
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
MacroGenics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for MacroGenics stock have an average target of 7.17, with a low estimate of 4.00 and a high estimate of 14. The average target predicts an increase of 125.47% from the current stock price of 3.18.
Analyst Consensus: Hold
* Price targets were last updated on Nov 6, 2024.
Analyst Ratings
The average analyst rating for MacroGenics stock from 10 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 6 | 7 | 7 | 7 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +25.79% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +25.79% | Sep 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +25.79% | Aug 21, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +340.25% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
161.40M
from 58.75M
Increased by 174.73%
Revenue Next Year
79.53M
from 161.40M
Decreased by -50.72%
EPS This Year
-1.36
from -0.15
EPS Next Year
-2.44
from -1.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 198.7M | 161.2M | 240.2M | |||
| Avg | 161.4M | 79.5M | 97.8M | |||
| Low | 130.3M | 20.8M | 21.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 238.2% | -0.1% | 202.0% | |||
| Avg | 174.7% | -50.7% | 22.9% | |||
| Low | 121.9% | -87.1% | -72.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.95 | -1.34 | -0.61 |
| Avg | -1.36 | -2.44 | -1.84 |
| Low | -1.75 | -3.19 | -3.38 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.